EZH2 Targeted Therapy Market Research 2026: Ipsen Leads With Tazverik, Hengrui and Pfizer Advance Next-Generation EZH2 Programs - Opportunities, Approved Drug Prices, Sales, Clinical Trials Insights [Yahoo! Finance]
TrumpRx has limited reach at launch beyond weight-loss drugs, experts say [Yahoo! Finance Canada]
Trump administration launches TrumpRx website for discounted drugs [Los Angeles Times (CA)]
Pfizer Inc. (PFE): A Bull Case Theory [Yahoo! Finance]
FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need